AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06721117 — intervention group
Intervention type: OTHER
Intervention: Grip strength assessment
Description: Jamar hand dynamometer, recommended by the American Hand Therapists Association and accepted as the gold standard in many studies due to its high validity and reliability, will be used to measure hand grip strength. Pinchmeter (Baseline Mechanical Pinch Gauge) will be used to measure fine grip strength. Hand grip and finger grip strength measurements will be made in the recommended standard position of sitting, shoulder adduction and neutral rotation, elbow 90 degrees flexed, forearm in mid-rotation and supported, wrist in neutral. In the test procedure, 3 measurements will be taken for hand grip and finger grip strengths with one-minute intervals between each measurement and the averages will be recorded.
Study NCT06721117 — intervention group
Intervention type: OTHER
Intervention: Forearm muscle strength assessment
Description: Wrist isometric muscle strength assessment will be performed with a handheld dynamometer (Lafayette Instrument Company, Lafayette, Indiana, USA). Patients will be placed in the supine, prone and sitting positions using the positions required for the fine muscle test method defined by Lovett and will be performed without compensatory movements. Wrist flexor and extensor muscles will be assessed. The values obtained with isometric contraction will be recorded in kg. Muscle strength measurements will be assessed bilaterally, in three repetitions for 5 seconds. The average value of the three repetition results will be recorded.
Study NCT04424121 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: CCTA
Description: Coronary Computed Tomography Angiography
Study NCT06504017 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: COG-TB: Cognitive Fusion guided prostate targeted Biopsy
Description: Cognitive Fusion guided targeted Biopsy 4 cores under cognitive fusion ultrasound
Study NCT06504017 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: FUS-TB: MRI-TRUS Fusion guided prostate targeted Biopsy
Description: MRI-TRUS Fusion guided targeted Biopsy 4 cores under cognitive fusion ultrasound
Study NCT05351008 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive Functional Therapy
Description: A physicaltheapy approach combining cognitive techniques, func-tional movement training, functional integration and Lifestyle Changes.
Study NCT05351008 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise program:
Description: Core strengthening program
Study NCT06216951 — intervention group
Intervention type: PROCEDURE
Intervention: Vital Pulpotomy
Description: Vital pulpotomy involves the removal of the coronal pulp, while MTA is used to seal the root orifices. It is clear that vital pulp treatments for symptomatic pulpitis are a more reliable, cost-effective, and generally easier option than root canal treatment (RCT) once the mineral trioxide aggregate (MTA) is introduced in dentistry. In vital pulpotomy, as opposed to RCT, tooth healing and symptoms are diminished while the vitality of the tooth is maintained. Furthermore, vital pulpotomy is a significantly more practical and economical treatment alternative than RCT.
Study NCT06078735 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Vascular closure with LockeT device
Description: For subjects that are assigned to the LockeT device arm, the healthcare professional will place the LockeT with suture above the wound to achieve compression instead of manually holding pressure on the sutures. After hemostasis is achieved and prior to ambulation the LockeT will be removed followed by suture removal.
Study NCT05126888 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCI-110
Description: SCI-110 - a softgel capsule containing Dronabinol and Palmitoylethanolamide (PEA) in the following doses: 2.5mg Dronabinol+400mg PEA, 5mg Dronabinol+400mg PEA and 10mg Dronabinol+400mg. Maximum dose 20mg Dronabinol and 800mg PEA a day.
Study NCT05126888 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Pill that matches in taste, odour and appearance to SCI-110 active pills
Study NCT05645627 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IBI112
Description: IBI112 by subcutaneous injection through week 16 ,and then will receive Dose 3 IBI112 by subcutaneous injection through week 48
Study NCT05645627 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo /IBI112
Description: placebo by subcutaneous injection cross over IBI112 by subcutaneous injection at week 16 through week 48
Study NCT04719910 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual exposure to taped food preparation
Description: Patients in the study group can watch the preparation of the the type of food she prefers to eat normally.
Study NCT04719910 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Visual exposure to topics not related to food
Description: Patients in the placebo group can choose a video that is relaxing but not related to food.
Study NCT06649630 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: SAD: Placebo will be administered intravenously.~MAD: Placebo will be administered orally.
Study NCT06594289 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: In laparoscopic hepatectomy, the subhepatic inferior vena cava was restricted and the patient was given non-restricted intraoperative fluid intake
Description: The specific steps of IVC blocking were performed by the principal physician under laparoscopic operation: slightly incision of the posterior peritoneum on both sides of the inferior vena cava above the level of the renal vein. The blood vessel blocking band is passed behind the inferior vena cava on the left or right side of the inferior vena cava. According to the intraoperative situation, the blocking band (flow limiting blocking/incomplete blocking of subhepatic inferior vena cava) was tightened to control the bleeding from hepatic vein on the liver section. Patients in this group did not use vasoactive drugs/underuse means to control CVP, so they need to strictly communicate with the anesthesiologist, and take the fluid intake based on the physiological requirements and fluid loss of individual patients (cancel the restriction of fluid intake).
Study NCT05260307 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: hearing aid condition
Description: The intervention will be a hearing aid or a modification to the sound stimulus that simulates a hearing aid configuration, style, or processing strategy.
Study NCT06510114 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: methylprednisolone(daily scheme)
Description: 0.5 g methylprednisolone i.v. daily for 5 consecutive days, followed by oral prednisone for 6 months. Oral prednisone started at 40 mg/day for 4 weeks and then the dose was tapered by 5 mg/day every 2-4 weeks.
Study NCT06510114 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: methylprednisolone(weekly scheme)
Description: 0.5 g methylprednisolone i.v. weekly for 6 weeks and then the dose was tapered by 0.25 g/week over the following 6 weeks.
Study NCT06229574 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: virtual reality glasses
Description: The breastfeeding software developed will be applied in this group.
Study NCT04988685 — intervention group
Intervention type: DEVICE
Intervention: Sirolimus Eluting Balloon
Description: PTCA with either a Sirolimus eluting balloon or Paclitaxel eluting balloon
Study NCT06440772 — intervention group
Intervention type: DRUG
Intervention: Ringer's Lactate Crystalloid Solutions
Description: 7 ml/kg ml of Ringer's Lactate is given in 10 min amongst initially tolerant fluid responders.
Study NCT06569069 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: US guided PE
Description: The multifidus muscle near the posterior dorsal root (at L4-L5 or L5-S1) was targeted using a transverse ultrasound view, inserting the needle at an 80º short axis or a 45º long axis, based on vessel presence. For the tibial nerve in the popliteal region, the needle was inserted at an 80º angle after a transverse cut of the nerve.~Physio invasiva® needles (0.30 x 40-60 mm) were used in the lumbar region, and 0.30 x 30 mm needles in the popliteal region. Both areas received galvanic current (1.5 mA for three seconds and three impacts). Treatment included three US-guided PE sessions over a 1:7:14 schedule, though two participants skipped the third due to pain resolution.
Study NCT06569069 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture
Description: Participants in the control group were also treated in a prone position. Sham acupuncture treatment was applied at the superficial level of the posterior face of the thigh on the affected side, using five Agupunt® needles of 0.16 x 25 mm, inserted superficially in the lateral aspect of the lumbar area (L3-L4), lateral gluteal region, greater trochanter, lateral part of the distal third of the thigh, head of the fibula and lateral aspect of the leg in its middle third. The needles were left superficially subcutaneously for 15 minutes, performing this approach in three different sessions, again following a periodicity of 1:7:14 days.
Study NCT06540586 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: anterior Quadratus lumborum block
Description: Patients are placed in the lateral decubitus position. The area where the block will be applied is disinfected with povidine iodine. A convex ultrasound probe is placed on the midaxillary line above the iliac crest. By visualizing the transverse process adjacent to the psoas major and quadratus lumborum muscles, using the in-plane technique, using a 22 gauge 80 mm peripheral block needle after negative aspiration into the anterior layer of the thoracolumbar fascia anterior to the quadratus lumborum muscle muscle, 0.5-1 ml of serum After observing hydrodissection with physiological, 25 ml of 0.25% bupivacaine is injected. The same is done to the opposite side.
Study NCT04777409 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Oral semaglutide once-daily, dose gradually increased to 14 mg. The study will last for up to 173 weeks
Study NCT04777409 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo (semaglutide)
Description: Oral placebo (semaglutide) once-daily. The study will last for up to 173 weeks
Study NCT06211647 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [177Lu]Lu-XT117
Description: \[177Lu\]Lu-XT117 is a radiopharmaceutical therapy in which an beta emitter, Lu-177, is conjugated to XT117. Patients will receive \[177Lu\]Lu-XT117 administration at fixed dose levels at an interval of 6 weeks between each dose.
Study NCT06139952 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Atorvastatin 80mg
Description: Atorvastatin 80mg taken Once before coronary angiography
Study NCT06139952 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80mg
Description: Atorvastatin 80mg taken Once before coronary angiography
Study NCT06139952 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: N-acetyl cysteine
Description: 200mg 3 times daily 2 days before coronary angiography
Study NCT06139952 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine
Description: 200mg 3 times daily 2 days before coronary angiography
Study NCT06139952 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Normal Saline
Description: adequate hydration using Normal Saline (1ml/kg/hr)
Study NCT05566340 — intervention group
Intervention type: PROCEDURE
Intervention: mitral valve repair
Description: Repair of mitral valve concomitant to aortic valve replacement.
Study NCT05510297 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: FitSitt Prototype
Description: FitSitt merges features of a posture chair, exercise machine, and tracking means. It provides seated stepping, postural support, and semi-recline capabilities. A digital interface and app will allow users to set goals and track performance.
Study NCT06250101 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Conversational Recast treatment
Description: In the context of child-friendly activities, the clinician prompts the child to attempt to use the grammatical form targeted in the treatment. The clinician immediately restates the child's attempt (i.e., the recast), correcting any ungrammatical elements. Clinicians elicit and recasts 24 utterances per session.
Study NCT06250101 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced Conversational Recast treatment
Description: In the context of child-friendly activities, the clinician prompts the child to attempt to use the grammatical form targeted in the treatment. The clinician immediately restates the child's attempt (i.e., the recast), correcting any ungrammatical elements. Clinicians elicit and recasts 24 utterances per session.
Study NCT06243497 — intervention group
Intervention type: PROCEDURE
Intervention: Ultrasound CycloPlasty
Description: All procedures were performed using the EyeOP1 device . The coupling cone was placed and adjusted on the centre of the patient's eye by visualising an equal white scleral ring surrounding the cornea. The coupling cone was kept in place via vacuum suction activated using a foot pedal and was then filled with a balanced salt solution to allow ultrasound transmission. The transducers were automatically activated at a frequency of 21 MHz and an acoustic power of 2.45 W, with an 8-s duration for each sector and a 20-s pause between each treatment to allow complete evacuation of heat.
Study NCT05388526 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: There was no intervention to be administered, only collection of data through various tests and questionnaires.
Study NCT04761523 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary intervention: reduced fat diet
Description: Participants will receive a dietary intervention, and will be proposed to adhere to a diet with a 15% fat, 65% carbohydrate, 20% protein content.
Study NCT06467526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Oral hydroxychloroquine (400mg/day) for 2 months
Study NCT06467526 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Steroid
Description: Oral prednisolone (5 mg) for 2 weeks (1 mg/kg/day for one week with gradually taper for another week with or without intratympanic dexamethasone 5 mg/ml injection for 2-4 times)
Study NCT06467526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Steroid
Description: Oral prednisolone (5 mg) for 2 weeks (1 mg/kg/day for one week with gradually taper for another week with or without intratympanic dexamethasone 5 mg/ml injection for 2-4 times)
Study NCT04761523 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary intervention: standard healthy diet
Description: Participants will receive a dietary intervention, and will be proposed to adhere to a diet with a 30% fat, 50% carbohydrate, 20% protein content.
Study NCT06203405 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Titrating sedation targeting both optimal P0.1 and appropriate arousal level
Description: * Sedation will be adjusted initially to target light sedation (RASS 0 to -2).~* Sedative drugs include IV fentanyl (25-75 mcg/h), midazolam (0.02- 0.1 mg/kg/h), propofol (5-50 mcg/kg/min), dexmedetomidine (0.2-0.7 mcg/kg/h).~* Deep sedation and neuromuscular blocking agents are allowed to facilitate mechanical ventilation adjustment in patients with refractory hypoxemia.~* Dose of cisatracurium is 0.15-0.2 mg/kg intravenous bolus, then continuous infusion at 5 -20 mg/h.~* Then sedation adjustment will be guided by P0.1 measurement.~* If P0.1 value of 1.5-3.5 cmH2O is achieved, no further adjustment is required.~* If P0.1 value \<1.5, sedation will be reduced.~* If P0.1 value >3.5, sedation will be increased.~* If P0.1 value is still >3.5 with deep sedation, cisatracurium will be allowed and titrated until P0.1 value \<3.5 cmH2O.~* The study protocol will be continued for 48 hours or until the patients are considered ready for weaning.
Study NCT06203405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fentanyl
Description: Continuous intravenous infusion of fentanyl 25-75 micrograms/hour
Study NCT06203405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Continuous intravenous infusion of midazolam 0.02 - 0.1 milligrams/kilogram/hour
Study NCT06203405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Continuous intravenous infusion of propofol 5 - 50 micrograms/kilogram/minute
Study NCT06203405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Description: Continuous intravenous infusion of dexmedetomidine 0.2 - 0.7 micrograms/kilogram/hour
Study NCT06203405 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisatracurium
Description: Continuous intravenous infusion of cisatracurium 5 - 20 milligrams/hour
Study NCT04762212 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mobilization with movement and stretching, stretching or control
Description: The participants will receive a therapist performed mobilization with movement and then instructed in a stretching program to be followed for one week or only receive instruction in a stretching program to be followed for one week on the hip with the greatest limitation in motion. The hip with the least amount of limitation will not receive an intervention.
Study NCT04852094 — intervention group
Intervention type: OTHER
Intervention: Qualitative focus group
Description: A qualitative focus group is performed with staff members and parents of hospitalised newborns in a NICU during Family-centered rounds management. The transcribed interviews are analyzed with qualitative content analysis in order to illuminate the experience, feelings and thoughts arisen among the staff members and the parents.
Study NCT05448664 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family HBM- mobile messaging
Description: The intervention will consist of two blocks of text messaging based on HBM model, the messages will be sent to the students and their parents in the following 24 weeks.
Study NCT05448664 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Adolescent HBM- mobile messaging
Description: The intervention will consist of two blocks of text messaging based on HBM model, the messages will be sent to the students in the following 24 weeks.
Study NCT05448664 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Adolescent e-pamphlets
Description: The contents of e-version of three pamphlets, published by Department of Health (http://www.toothclub.gov.hk/en/en_index.html) will be distributed in an electronic form and sent via a mobile message.
Study NCT05910762 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Associative inference
Description: Participants will engage in an associative inference paradigm. Memory will be assessed behaviorally and neural representations will be assessed using functional magnetic resonance imaging.
Study NCT05910762 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Category learning
Description: Participants will engage in a category learning paradigm. Memory will be assessed behaviorally (Arms 2 and 3), and neural representations will be assessed using functional magnetic resonance imaging (Arm 2).
Study NCT05910762 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep
Description: Participants will sleep after engaging in a category learning paradigm while electroencephalography data are collected, and memory will be assessed behaviorally after sleep.
Study NCT06387303 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Methadone
Description: Intravenous Methadone
Study NCT06387303 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Morphine
Description: Intrathecal Morphine
Study NCT06426797 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cadonilimab plus anlotinib
Description: cadonilimab (10mg/Kg, ivgtt, d1) and anlotinib (12mg, P.O., d1-d14) on a 21-day regimen for 3 cycles
Study NCT05131893 — intervention group
Intervention type: DRUG
Intervention: Tamoxifen
Description: endocrine therapy
Study NCT05131893 — intervention group
Intervention type: DRUG
Intervention: Goserelin
Description: endocrine therapy
Study NCT05131893 — intervention group
Intervention type: DRUG
Intervention: Letrozole 2.5Mg Tab
Description: endocrine therapy
Study NCT05131893 — intervention group
Intervention type: DRUG
Intervention: Epirubicin
Description: chemotherapy
Study NCT04824534 — intervention group
Intervention type: OTHER
Intervention: Motion analysis
Description: Motion analysis is performed in the Motionlab using Vicon systems. Surgery (in case of SI patients) is performed with iFuse implant system for sacroiliac joint fusion
Study NCT05131893 — intervention group
Intervention type: DRUG
Intervention: cyclophosphamide
Description: chemotherapy
Study NCT06454981 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hemodiafilter
Description: The enrolled patients were randomly divided into the experimental group and the control group, using the hemodiafilter (experimental device) produced by Shinva Medical Instrument Co.,Ltd.
Study NCT06454981 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Fresenius Medical Care AG & Co.KGaA
Description: The enrolled patients were randomly divided into the experimental group and the control group, using the FX 800HDF hollow fiber hemodialysis/filter (control device) produced by Fresenius Medical Care AG \& Co.KGaA (registered agent: Fresenius Medical Care (shanghai) Company Limted).
Study NCT06245070 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation
Description: HD electrodes (diameter of 1.2 cm) will be placed on the participants' skull using an HD-tDCS cap (Soterix Medical Inc. New York) and based on 5-10 international montage. Active stimulations will be delivered by a 9 MxN Soterix HD-tES device for 20 minutes( 2 mA) per day for 5 days.